What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook

Publication

Article

January 11, 2023

Pharmaceutical Executive

Pharmaceutical Executive: January 2023

Volume43

Issue 01

What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook

Exploring the most relevant topics affecting the biopharma industry as the new year gets underway—ranging from trends ripe with risk and opportunity to those driving more definitive growth opportunities in patient care.

Our 2023 trends:

Inflation Reduction Act

Partnering with Academia

Download Issue PDF

Articles in this issue

Key Factors Attributing to a Successful Product Launch

Closing the Digital Gap: FDA’s Oversight of Social Media

Sales-Rep Compensation: Adding Long-Term Incentives to Mix

Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff

Co-creating New Innovations

The Potential Impact of the IRA

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook

Newsletter